Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

NCCN Practice Guidelines for Head and Neck Cancers

D G Pfister¹, K Ang, B Brockstein

¹Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Oncology (Williston Park, N.Y.)

|February 24, 2001

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinoma.

ESMO open·2026

Same author

Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY.

medRxiv : the preprint server for health sciences·2024

Same author

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes.

The British journal of dermatology·2020

Same author

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.

Annals of oncology : official journal of the European Society for Medical Oncology·2019